BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38406077)

  • 1. ST-Segment Elevation Myocardial Infarction Caused by 5-Fluorouracil-Related Cardiotoxicity.
    Balaji N; Dixit P; Adams AM; Faiz F; Ngwainmbi D; Henry G; Ghasemzadeh N
    Cureus; 2024 Jan; 16(1):e52864. PubMed ID: 38406077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
    Karakulak UN; Aladağ E; Maharjan N; Övünç K
    Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil-related Cardiotoxicity with Coronary Vasospasms.
    Faheem B; Kania B; Ashkar H; Bondili L; Maroules M
    J Community Hosp Intern Med Perspect; 2022; 12(5):71-74. PubMed ID: 36262502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What the Cardiologist Needs to Consider in the Management of Oncologic Patients with STEMI-Like Syndrome: A Case Report and Literature Review.
    Aleksova A; Gagno G; Pierri A; Todaro C; Fluca AL; Orlando V; Guglielmi A; Beltrami AP; Sinagra G
    Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34204714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and Management of a Patient With 5-Fluorouracil-Induced ST Elevation and Nonsustained Ventricular Tachycardia as a Late Presentation of Cardiotoxicity and Successful 5-Fluorouracil Rechallenge.
    Medepalli LC; Mahmood TS; Liberman H; Medepalli AM; Bagwell TW
    Cureus; 2022 Oct; 14(10):e30489. PubMed ID: 36415417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.
    Kosmas C; Kallistratos MS; Kopterides P; Syrios J; Skopelitis H; Mylonakis N; Karabelis A; Tsavaris N
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):75-82. PubMed ID: 17636329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
    Dyhl-Polk A; Vaage-Nilsen M; Schou M; Vistisen KK; Lund CM; Kümler T; Appel JM; Nielsen DL
    Acta Oncol; 2020 Apr; 59(4):475-483. PubMed ID: 31931649
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoropyrimidine-Associated Cardiotoxicity.
    Kanduri J; More LA; Godishala A; Asnani A
    Cardiol Clin; 2019 Nov; 37(4):399-405. PubMed ID: 31587781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for remote ischemic conditioning in preventing 5-fluorouracil-induced coronary vasospasm?
    Chong J; Ho AF; Yap J; Bulluck H; Hausenloy DJ
    Cond Med; 2019 Oct; 2(5):204-212. PubMed ID: 32133437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capecitabine-mediated heart failure in colorectal cancer: a case series.
    McAndrew EN; Jassal DS; Goldenberg BA; Kim CA
    Eur Heart J Case Rep; 2021 Mar; 5(3):ytab079. PubMed ID: 33709051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-fluorouracil and cardiotoxicity: a review.
    Sara JD; Kaur J; Khodadadi R; Rehman M; Lobo R; Chakrabarti S; Herrmann J; Lerman A; Grothey A
    Ther Adv Med Oncol; 2018; 10():1758835918780140. PubMed ID: 29977352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the long-term outcomes in chronic coronary syndrome patients with prior ST-segment and non-ST-segment elevation myocardial infarction: findings from the TIGRIS registry.
    Krishnamurthy SN; Pocock S; Kaul P; Owen R; Goodman SG; Granger CB; Nicolau JC; Simon T; Westermann D; Yasuda S; Andersson K; Brandrup-Wognsen G; Hunt PR; Brieger DB; Cohen MG
    BMJ Open; 2023 Dec; 13(12):e070237. PubMed ID: 38110389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity related to 5-fluorouracil chemotherapy: a report of two cases.
    Weng MC; Wang WB; Chao TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Mar; 55(3):266-9. PubMed ID: 7780886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.
    Shah NR; Shah A; Rather A
    J Oncol Pharm Pract; 2012 Mar; 18(1):132-5. PubMed ID: 21321041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
    Huang L; Zhang J; Huang Q; Cui R; Chen J
    BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine.
    Chakrabarti S; Sara J; Lobo R; Eiring R; Finnes H; Mitchell J; Hartgers M; Okano A; Halfdanarson T; Grothey A
    Clin Colorectal Cancer; 2019 Mar; 18(1):52-57. PubMed ID: 30396850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study.
    Peng J; Dong C; Wang C; Li W; Yu H; Zhang M; Zhao Q; Zhu B; Zhang J; Li W; Wang F; Wu Q; Zhou W; Yuan Y; Qiu M; Chen G
    Cancer Commun (Lond); 2018 May; 38(1):22. PubMed ID: 29764506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bolus fluorouracil induced syncope and pulseless ventricular tachycardia: a case report.
    Fidan E; Fidan S; Yildiz B; Durmus I; Kavgaci H; Ozdemir F; Aydin F
    Hippokratia; 2011 Jan; 15(1):93-5. PubMed ID: 21607046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.